| Protocol ID |
|
Title |
|
| C-205 |
|
Phase IIB, Multicenter, Randomized, Open-Label trial of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection v. Intensive Salvage Therapy in Adult Patients < 60 Years Old with AML in First Relapse Following an Initial CR > 1 Month Duration
Keywords: AML in First Relapse Following an Initial CR > 1 Month Duration |
|
| C10403 |
|
An Intergroup Phase II Clinical Trial of Adolecents and Young Adults with Untreated Acute Lymphoblastic Leukemia
Keywords: Adolecents and Young Adults with Untreated Acute Lymphoblastic Leukemia |
|
| In-House |
|
Skin Biopsy and Use of Normal Donor Apheresis Product in Laboratory Validation Studies
Keywords: skin biopsy |
|
| In-House |
|
Haploidentical Hematopoietic Stem Cell Transplantation (HCT) Using Highly Purified Hematopoietic Stem Cells
Keywords: haploidentical hematopoietic stem cell transplantation |
|
| In-House |
|
Laboratory Studies of Iron Metabolism in Blood Cells from Patients with Hematochromatosis
Keywords: patients with hematochromatosis |
|
| In-House |
|
Pre-Clinical Evaluation of Gallium Compounds in Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia (CLL) |
|
| FH 1803.00 |
|
Donor Lymphocyte Infusion for the Treatment of Malignancy After Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning - A Multi-Center Trial
Keywords: after hematopoitic cell transplantation |
|
| FH 1813.00 |
|
A Multi-Center Phase III Study Comparing Nonmyeloablative Conditioning with TBI versus Fludarabine/TBI for HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Keywords: HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies |
|
| FH 1938.00 |
|
A Randomized Phase III Study to Determine the Most Promising Post grafting Immunosuppression for Prevention of Acute GVHD after Unrelated Donor G-CSF Mobilized Peripheral Blood Mononuclear Cell (G-PBMC) Transplantation Using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A Multi-Center Trial
Keywords: after Unrelated Donor G-CSF Mobilized Peripheral Blood Mononuclear Cell (G-PBMC) Transplantation |
|
| FH 2054.00 |
|
Cyclophosphamide and Antithymocyte Globulin Conditioning Regimen for Marrow Transplantation from HLA-Matched Family Members for Severe Aplastic Anemia: Effect of Marrow Cell Dose on Chronic Graft-vs. Host Disease: A Multi-Center Trial
Keywords: Severe Aplastic Anemia |
|
| FH 2239.00 |
|
Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematologic Malignancies Using Reduced -Intensity Preparative Regimen
Keywords: Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematologic Malignancies |
|
| U of M |
|
A Multicenter, Prospective Trial to Evaluate the Role of NK Cell Kir Epitope Mismatch on Mortality and Disease Relapse in T-Cell Depleted Hematopoietic Stem Cell Transplantation from HLA-C Mismatched, Unrelated Donors for Myeloid Malignancies
Keywords: hematopoietic stem cell transplants and myeloid malignancies |
|
| In-House:EBV Auto |
|
A Study of Cellular Adoptive Immunotherapy as Treatment for EBV-LPD; Use of Autologous Epstein Barr Virus Specific Cytotoxic T-Lymphoctyes
Keywords: Treatment for Epstein Barr Virus |
|
| In-House: T-Cell |
|
A Single Arm, Phase II Trial of Transplantation of HLA-Identical Sibling, CD34+ Enriched, Peripheral Blood Stem Cells Isolated by the Isolex System with a Fixed T-Cell Dose in the Treatment of Patients with Hematologic Malignancies
Keywords: Hematologic Malignancies |
|
In-House: Pre-Clinical
Vaccine for MM |
|
Pre-Clinical Studies on Vaccine Derived From Patient-Derived Myeloma Cells
Keywords: Multiple Myeloma |
|
| In-House Zometa |
|
A Randomized Phase II Study of Zoledronic Acid (Zometa ®) in the Prevention of Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Keywords: allogenic hematopoietic stem cell transplant |
|
| In-House: Technetium |
|
Development of 99m Technetium Scanning as a Quantitative in Vivo Assay to Predict Chemotherapy Drug Resistance and Clinical Outcome in Lymphoma Patients
Keywords: Lymphoma |
|
| Seattle 1992.00 |
|
A Multi-Center Phase III Study Comparing Myeloablative to Nonmyeloablative Transplant Conditioning in Patients with Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Keywords: Myelodysplastic Syndrome or Acute Myelogenous Leukemia |
|
| Washington University |
|
A Phase II Multicenter Study of Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Keywords: Relapsed or Refractory Classical Hodgkin Lymphoma |
|
| SCOT |
|
A Randomized , Open label, Phase II/III Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation with Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis
Keywords: Severe Systemic Sclerosis |
|
| CIBMTR 07-REV |
|
Evaluation of Lenalidominde as Maintenance Therapy Post Allogeneic Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma
Keywords: Post Allogeneic Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma |
|
| NMDP/ CIBMTR |
|
The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family: A Pilot Study
Keywords: Financial Impact of Allogeneic Stem Cell Transplantation |
|
| Industry AML/ALL |
|
A Phase II Study of SCH 727965 in Subjects with Relapsed and Refractory Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia
Keywords: Relapsed and Refractory Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia |
|
| Jak 2 |
|
A Randomized, Double-Blind, Placebo-Controlled Study of the JAK Inhibitor INCB018424 Tablets Administered Orally to Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera- Myelofibrosis (PPV-MF) or Post Essential Thrombocythemia-Myelofibrosis (PET-MF)
Keywords: Primary Myelofibrosis (PMF), Post-Polycythemia Vera- Myelofibrosis (PPV-MF) or Post Essential Thrombocythemia-Myelofibrosis (PET-MF) |
|
| FH 2184.00 |
|
Chronic GVHD Protocol: Improving Outcomes Assessment in Chronic GVHD
Keywords: Chronic GVHD |
|
| In-House: Haplo-Cord |
|
Phase II Study: Myeloablative Human Stem Cell Transplant (HSCT) Using Selected Mismatched Related Donor and One Umbilical Cord Unit
Keywords: Human Stem Cell Transplant |
|
| S0521 |
|
A Randomized Trial of Maintenance v. Observation for Patients with Previously Untreated Low and Intermediate Risk Acute Promyelocytic Leukemia (APL), Phase II
Keywords: Previously Untreated Low and Intermediate Risk Acute Promyelocytic Leukemia (APL) |
|
| E2903 |
|
Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Campath-1H for Previously Treated Relapsed or Refractory Patients with Chronic Lymphocytic Leukemia
Keywords: Previously Treated Relapsed or Refractory Patients with Chronic Lymphocytic Leukemia |
|
| E2905 |
|
Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid ®) Alone in Combination with Epoetin Alfa (Procrit ®) in Subjects with Low- or Intermediate -1 Risk MDS and Symptomatic Anemia
Keywords: Low- or Intermediate -1 Risk MDS and Symptomatic Anemia |
|
| Industry 095 |
|
An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination with Bortezomib in Patients with Relapsed and Refractory Multiple Myeloma
Keywords: Patients with Relapsed and Refractory Multiple Myeloma |
|